BackAscelia Pharma AB (publ) Overview

Ascelia Pharma AB (publ) Total Assets

Ascelia Pharma AB (publ)'s total assets is $100M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$100.23M
↓ 20.03% YoYΔ $-25.10M vs prior year quarter

Peer trimmed avg / median

Loading

Ascelia Pharma AB (publ) Total Assets History

Loading

Ascelia Pharma AB (publ) vs. peers: Total Assets Comparison

Loading

Ascelia Pharma AB (publ) Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Ascelia Pharma AB (publ) (ACE.ST) FAQ

The latest total assets for ACE.ST is $100M as of June 2026. That compares with $130M in the prior-year period — down 20.0% year over year. Investors often review this figure alongside Ascelia Pharma AB (publ)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, ACE.ST's total assets moved from $130M to $100M — a 20.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Ascelia Pharma AB (publ)'s operating scale or balance-sheet position.

A total assets figure of $100M for ACE.ST is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ACE.ST's total assets ($100M), review year-over-year change from $130M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Ascelia Pharma AB (publ)'s total assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.